Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Faloppi, Luca
OINC, NCT04480268: PAXG Out in the Country	Recruiting	4	175	Europe	PAXG regimen (cisplatin, nab-paclitaxel, capecitabine, gemcitabine) chemotherapy	IRCCS San Raffaele	Pancreatic Ductal Adenocarcinoma	01/22	01/26
CASSANDRA, NCT04793932: Short-course Versus Long-course Pre-operative Chemotherapy With mFOLFIRINOX or PAXG ( TRIAL)	Recruiting	2	261	Europe	PAXG, mFOLFIRINOX, short-course chemotherapy, long-course chemotherapy	Associazione Italiana per lo Studio del Pancreas, High Research srl, Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente	Pancreas Ductal Adenocarcinoma	11/21	11/23